» Articles » PMID: 35717355

Amputation and Infection Are the Greatest Fears in Patients with Diabetes Foot Complications

Overview
Specialty Endocrinology
Date 2022 Jun 18
PMID 35717355
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To determine the degree patients with diabetic foot ulcers, Charcot neuroarthropathy and neuropathic fractures and dislocations fear complications (death, dialysis, heart attack, stroke, blindness, diabetic foot infection, minor and major lower extremity amputation [LEA]) that can occur and to assess if there is a difference between fears of patients with diabetic foot ulcers, Charcot neuroarthropathy and neuropathic fractures and dislocations and diabetic patients without these complications.

Methods: 478 patients completed an eight question Likert scale survey. The study group was defined as non-infected foot ulcers, neuropathic fractures and Charcot neuroarthropathy.

Results: Of the 478 patients, 121 (25.3 %) had diabetic foot ulcers, Charcot neuroarthropathy or neuropathic fractures and dislocations and 357 (74.7 %) did not. The study group had significantly higher odds of reporting extreme fear of foot infection (OR 2.8, 95 % CI 1.8-4.5), major LEA (OR 2.8, 95 % CI 1.8-4.4), minor LEA (OR 2.3, 95 % CI 1.5-3.5), blindness (OR 2.0, 95 % CI 1.3-3.2), dialysis (OR 2.0, 95 % CI 1.1-3.3), and death (OR 2.4, 95 % CI 1.4-4.2). In the study group highest rated fear measures were foot infection (3.71, SD 1.23), minor amputation (3.67, SD 1.45) and major amputation (3.63, SD 1.52). There were no significant differences in the mean fear of infection, minor amputation or major amputation.

Conclusion: Patients with diabetic foot ulcers, Charcot neuroarthropathy or neuropathic fractures and dislocations reported higher fear ratings of diabetes-related complications compared to those without these complications.

Citing Articles

Does complete resection of infected bone improve clinical outcomes in patients with diabetic foot osteomyelitis?.

Lavery L, Tarricone A, Reyes M, Suludere M, Sideman M, Siah M Int Wound J. 2024; 21(10):e70072.

PMID: 39375181 PMC: 11458324. DOI: 10.1111/iwj.70072.


Diabetic peripheral neuropathy and neuromodulation techniques: a systematic review of progress and prospects.

Mittal R, McKenna K, Keith G, McKenna E, Lemos J, Mittal J Neural Regen Res. 2024; 20(8):2218-2230.

PMID: 39359078 PMC: 11759018. DOI: 10.4103/NRR.NRR-D-24-00270.


Advances in the treatment of diabetic peripheral neuropathy by modulating gut microbiota with traditional Chinese medicine.

Li Y, Guan R, Hong Z, Wang Y, Pan L World J Diabetes. 2024; 15(8):1712-1716.

PMID: 39192853 PMC: 11346088. DOI: 10.4239/wjd.v15.i8.1712.


Type 2 Diabetes Mellitus and Cardiometabolic Prospects: A Rapid Narrative Review.

Chowdhury K, Sinha S, Ahmad R, Lugova H, Mehta M, Kumar S Cureus. 2024; 16(7):e65808.

PMID: 39092382 PMC: 11293072. DOI: 10.7759/cureus.65808.


Patients' Expectations of Evidence-Based Service at the Pharmacy Regarding Information on Self-Care of the Feet for Persons with Diabetes at Risk of Developing Foot Ulcers - A Cross-Sectional Observational Study in Sweden.

Hellstrand Tang U, Scandurra I, Sundberg L, Annersten Gershater M, Zugner R Patient Prefer Adherence. 2024; 17:3557-3576.

PMID: 38169667 PMC: 10758569. DOI: 10.2147/PPA.S435632.